What is "CATALYST" for Black women?
“Community Assessment and Tools for increasing Access to LA ART: Yielding Solutions Together (CATALYST)” is a mixed methods study led by Emory University in partnership with the Centers for Disease Control and Prevention (CDC). The goal of the study is to evaluate implementation and scale-up of long-acting antiretroviral therapy (ART) for Black women with HIV in the U.S. South. Specifically, CATALYST leverages academic and community partnerships to bring together HIV medical and social service providers with Black women with HIV using human centered design.
Despite advancements in oral ART, obstacles still exist to achieving HIV control with a daily pill regimen. Long-acting ART may help overcome some of these barriers to HIV treatment access and adherence. Further investigation of barriers to and suggestions for improved long-acting ART access and uptake among Black women in the South is required. CATALYST aims to explore facilitators and barriers to current and future long-acting ART options through surveys and in-depth interviews. CATALYST will bring Black women with HIV and providers together for a workshop series to co-create tools to support long-acting ART uptake and persistence.
With a special focus on the Southern U.S., CATALYST will recruit Black women with HIV and providers from clinics and community-based organizations in urban and rural settings. To do this, CATALYST will leverage the Study of Treatment and Reproductive Outcomes (STAR) network (with sites located in Atlanta, Miami, Alabama, Mississippi, North Carolina, and Washington D.C.) as well as other HIV-related provider networks and community partnerships.
CATALYST Site Map
Sources of support: Funding was provided by a cooperative agreement (RFA-PS-23-003) from the Centers for Disease Control and Prevention. To view details of this award, visit www.grants.gov and click on the “Search Grants” tab. Then enter “RFA-PS23-003” into the “Basic Search Criteria-Opportunity Announcement.